CRT 2025

CardioTube Interview

CardioTube Interview | Status of women in Interventional Cardiology

Interviewee(s)

• 

  Suzanne J. Baron, MD, MSc

  Interventional Cardiologist
  Massachusetts General Hospital
  Winchester, Massachusetts, United States

  Disclosure(s): Abiomed Inc: Grant/Research Support (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Janssen: Consultant (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); PiCardia: Consultant (Ongoing); Shockwave Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Zoll Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Interviewer(s)

• 

  Brian C. Case, MD

  Interventional Cardiologist; Assistant Professor of Medicine, Georgetown University; Director of Cath Lab, Chief of Interventional Cardiology, MedStar Southern Maryland Hospital
  MedStar Heart and Vascular Institute
  Bethesda, Maryland, United States

  Disclosure(s): Acist Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips Medical Systems, Inc.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)